Electronic messaging support service programs improve adherence to lipid‐lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study

Fang, Ronghua; Li, Xia

doi:10.1111/jocn.12988

Cited by 45 publications

(79 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Using a sample of 280 outpatients, Fang and Li46 examined the effectiveness of an electronic messaging support service programme as a means of providing discharged patients with reminders and coronary artery disease-related health information. Fang and Li46 found that compared with the control group who received phone calls, the group who received medication reminders via short message service (SMS) had better cumulative adherence to lipid-lowering therapy after 6 months of the programme.…”

Section: Resultsmentioning

confidence: 99%

“…Fang and Li46 found that compared with the control group who received phone calls, the group who received medication reminders via short message service (SMS) had better cumulative adherence to lipid-lowering therapy after 6 months of the programme.…”

Section: Resultsmentioning

confidence: 99%

“…Fang and Li46 built a public platform on one of the most popular mobile apps in China called WeChat. From a computer, healthcare providers regularly released to the WeChat platform CHD-related information on cardioprotective medication, including its function, method of use and side effects.…”

Section: Resultsmentioning

confidence: 99%

“…From a computer, healthcare providers regularly released to the WeChat platform CHD-related information on cardioprotective medication, including its function, method of use and side effects. Patients in the experimental group had open access to all information on the WeChat platform 46. Fang and Li46 found that compared with the control group, the experimental group had better cumulative adherence to lipid-lowering therapy after 6 months of the programme.…”

Section: Resultsmentioning

confidence: 99%

“…Patients in the experimental group had open access to all information on the WeChat platform 46. Fang and Li46 found that compared with the control group, the experimental group had better cumulative adherence to lipid-lowering therapy after 6 months of the programme.…”

Section: Resultsmentioning

confidence: 99%

See 4 more Smart Citations

Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review

Dardas

et al. 2019

Heart Asia

View full text Add to dashboard Cite

In China, poor cardioprotective medication adherence is a key reason for the high mortality rate of coronary heart disease (CHD). The aims of this systematic review are to (1) describe and synthesise factors that influence medication adherence among Chinese people with CHD, (2) evaluate the current status of intervention studies, and (3) discuss directions of future research to improve medication adherence. A comprehensive search using PubMed, Cumulative Index to Nursing and Allied Health Literature, Embase, Scopus, Global Health and PsycINFO was undertaken to describe poor adherence in China. Thirty-three eligible articles were included in the study. The review shows that there are multiple contributing factors to poor medication adherence, including patients’ sociodemographic characteristics, health status and medication characteristics. In addition, from patients’ perspective, lack of medication-related knowledge, such as the name, function, dosage and frequency, contributes to poor adherence. From physicians’ perspective, a gap exists between CHD secondary prevention guidelines and clinical practice in China. Follow-up phone calls, educational lectures, booklets and reminder cards were common methods found to be effective in improving medication adherence. This systematic review indicates that cardioprotective medications were commonly prescribed as secondary prevention medication to patients with CHD in China, but adherence to these medications gradually decreased during a follow-up period. Therefore, more research should be conducted on how to establish high-quality health educational programmes aimed at increasing patients’ medication adherence.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review

Dardas

et al. 2019

Heart Asia

View full text Add to dashboard Cite

show abstract

Interventions to improve adherence to lipid-lowering medication

Schedlbauer

Schroeder²,

Peters³

et al. 2016

Cochrane Database of Systematic Reviews

161

View full text Add to dashboard Cite

show abstract

Patient education in the management of coronary heart disease

Anderson

Brown

Clark

et al. 2017

Cochrane Database of Systematic Reviews

163

128

View full text Add to dashboard Cite

Cochrane Database of Systematic Reviews Data collection and analysis Two review authors independently screened all identified references for inclusion based on the above inclusion criteria. One author extracted study characteristics from the included trials and assessed their risk of bias; a second review author checked data. Two independent reviewers extracted outcome data onto a standardised collection form. For dichotomous variables, risk ratios and 95% confidence intervals (CI) were derived for each outcome. Heterogeneity amongst included studies was explored qualitatively and quantitatively. Where appropriate and possible, results from included studies were combined for each outcome to give an overall estimate of treatment e ect. Given the degree of clinical heterogeneity seen in participant selection, interventions and comparators across studies, we decided it was appropriate to pool studies using random-e ects modelling. We planned to undertake subgroup analysis and stratified meta-analysis, sensitivity analysis and meta-regression to examine potential treatment e ect modifiers. We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to evaluate the quality of the evidence and the GRADE profiler (GRADEpro GDT) to create summary of findings tables. Main results This updated review included a total of 22 trials which randomised 76,864 people with CHD to an education intervention or a 'no education' comparator. Nine new trials (8215 people) were included for this update. We judged most included studies as low risk of bias across most domains. Educational 'dose' ranged from one 40 minute face-to-face session plus a 15 minute follow-up call, to a four-week residential stay with 11 months of follow-up sessions. Control groups received usual medical care, typically consisting of referral to an outpatient cardiologist, primary care physician, or both. We found no di erence in e ect of education-based interventions on total mortality (13 studies, 10,075 participants; 189/5187 (3.6%) versus 222/4888 (4.6%); random e ects risk ratio (RR) 0.80, 95% CI 0.60 to 1.05; moderate quality evidence). Individual causes of mortality were reported rarely, and we were unable to report separate results for cardiovascular mortality or non-cardiovascular mortality. There was no evidence of a di erence in e ect of education-based interventions on fatal and/or non fatal myocardial infarction (MI) (2 studies, 209 participants; 7/107 (6.5%) versus 12/102 (11.8%); random e ects RR 0.63, 95% CI 0.26 to 1.48; very low quality of evidence). However, there was some evidence of a reduction with education in fatal and/or non-fatal cardiovascular events (2 studies, 310 studies; 21/152 (13.8%) versus 61/158 (38.6%); random e ects RR 0.36, 95% CI 0.23 to 0.56; low quality evidence). There was no evidence of a di erence in e ect of education on the rate of total revascularisations (3 studies, 456 participants; 5/228 (2.2%) versus 8/228 (3.5%); random e ects RR 0.58, 95% CI 0.19 to 1.71; very low quality evide...

show abstract

Electronic messaging support service programs improve adherence to lipid‐lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study

Abstract: This research offers useful information to help medical staff design effective interventions to improve medication compliance among coronary artery disease patients.

Cited by 45 publications

References 27 publications

Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review

Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review

Interventions to improve adherence to lipid-lowering medication

Patient education in the management of coronary heart disease

Contact Info

Product

Resources

About